Letter to the Editor: Cannabis use and clinical outcomes of rTMS among adults with major depressive disorder: Insights from a naturalistic clinical cohort
Brain Stimulation · 2027-01 · 20 (1) · 103249
DOI: 10.1016/j.brs.2026.103249 ↗Kurz gefasst
Leserbrief in der Zeitschrift Brain Stimulation, 2027-01. Verfasst von S K Segal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Family Care Center, P.LLC, TMS Center of Excellence, 19105 N Highway 281, Ste 101, San Antonio, TX, 78258, USA. Electronic address: ssegal@fccsprings…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cannabis is the most consumed drug, according to the United Nations Office on Drugs and Crime World Drug Report 2025 [1]. Cannabis users have a high prevalence of depressive disorders (25%), with 19.24% being diagnosed with major depressive disorder (MDD) [2]. Cannabis use has been Click or tap here to enter text.associated with reduced cortical inhibition in single or paired-pulse repetitive TMS Click or tap here to enter text.(rTMS). According to one study on rTMS for MDD, cannabis use does not appear to impact clinical outcomes [5].
Autor:innen und Institutionen
- Family Care Center, P.LLC, TMS Center of Excellence, 19105 N Highway 281, Ste 101, San Antonio, TX, 78258, USA. Electronic address: ssegal@fccsprings.com.
- Family Care Center, P.LLC, TMS Center of Excellence, 19105 N Highway 281, Ste 101, San Antonio, TX, 78258, USA.
Zitieren
APA
Segal, S. K., Weber, C. L., Chowdhury, M. A. B., Gruschkus, S. K., & Ivany, C. G. (2027). Letter to the Editor: Cannabis use and clinical outcomes of rTMS among adults with major depressive disorder: Insights from a naturalistic clinical cohort. Brain Stimulation, 20(1), 103249. https://doi.org/10.1016/j.brs.2026.103249
Vancouver
Segal SK, Weber CL, Chowdhury MAB, Gruschkus SK, Ivany CG. Letter to the Editor: Cannabis use and clinical outcomes of rTMS among adults with major depressive disorder: Insights from a naturalistic clinical cohort. Brain Stimulation. 2027;20(1):103249. doi:10.1016/j.brs.2026.103249
BibTeX
@article{Segal2027,
author = {Segal, S K and Weber, C L and Chowdhury, M A B and Gruschkus, S K and Ivany, C G},
title = {Letter to the Editor: Cannabis use and clinical outcomes of rTMS among adults with major depressive disorder: Insights from a naturalistic clinical cohort},
journal = {Brain Stimulation},
year = {2027},
volume = {20},
number = {1},
pages = {103249},
doi = {10.1016/j.brs.2026.103249}
}
EUVIMED